Literature DB >> 10980759

COX-2-Selective NSAIDs: new and improved?

D R Lichtenstein, M M Wolfe.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10980759     DOI: 10.1001/jama.284.10.1297

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  Journals should see original protocols for clinical trials.

Authors:  C J Hawkey
Journal:  BMJ       Date:  2001-12-01

2.  Short-term administration of non-selective and selective COX-2 NSAIDs do not interfere with bone repair in rats.

Authors:  Mariza Akemi Matsumoto; Angelita De Oliveira; Paulo Domingos Ribeiro Junior; Hugo Nary Filho; Daniel Araki Ribeiro
Journal:  J Mol Histol       Date:  2008-07-01       Impact factor: 2.611

3.  Effect of COX-2 inhibitor lumiracoxib and the TNF-α antagonist etanercept on TNBS-induced colitis in Wistar rats.

Authors:  Ana Paula Ribeiro Paiotti; Daniel Araki Ribeiro; Roseane Mendes Silva; Patrícia Marchi; Celina Tizuko Fujiyama Oshima; Ricardo Artigiani Neto; Sender Jankiel Miszputen; Marcello Franco
Journal:  J Mol Histol       Date:  2012-03-20       Impact factor: 2.611

4.  Design, Synthesis, and Anti-Inflammatory Activity of Some Coumarin Schiff Base Derivatives: In silico and in vitro Study.

Authors:  Shokhan J Hamid; Twana Salih
Journal:  Drug Des Devel Ther       Date:  2022-07-14       Impact factor: 4.319

Review 5.  Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis.

Authors:  Michael T Nurmohamed; Vokko P van Halm; Ben A C Dijkmans
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Effect of COX-2 inhibitor after TNBS-induced colitis in Wistar rats.

Authors:  Ana Paula Ribeiro Paiotti; Sender Jankiel Miszputen; Celina Tizuko Fujiyama Oshima; Henrique de Oliveira Costa; Daniel Araki Ribeiro; Marcello Franco
Journal:  J Mol Histol       Date:  2009-11-22       Impact factor: 2.611

7.  Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer.

Authors:  M Yao; E C Lam; C R Kelly; W Zhou; M M Wolfe
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

8.  Revision of Commonly Accepted Warburg Mechanism of Cancer Development: Redox-Sensitive Mitochondrial Cytochromes in Breast and Brain Cancers by Raman Imaging.

Authors:  Halina Abramczyk; Jakub Maciej Surmacki; Beata Brozek-Pluska; Monika Kopec
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

9.  Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.

Authors:  Yola Moride; Thierry Ducruet; Jean-François Boivin; Nicholas Moore; Sylvie Perreault; Sean Zhao
Journal:  Arthritis Res Ther       Date:  2005-01-17       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.